Parallax Volatility Advisers »

Beam Therapeutics shares owned by Parallax Volatility Advisers

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Parallax Volatility Advisers from 13F filings

Historical chart of Parallax Volatility Advisers investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Parallax Volatility Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Parallax Volatility Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $201k 7.4k 27.22
2021-06-30 $1.7M 13k 130.00
2021-03-31 $1.1M 14k 80.00

More positions owned by Parallax Volatility Advisers

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Meta Platforms Cl A Call Option (META)
NVIDIA Corporation (NVDA)
Tesla Motors Call Option (TSLA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr Gold Tr Gold Shs Put Option (GLD)
Select Sector Spdr Tr Energy (XLE)
Pdd Holdings Sponsored Ads Put Option (PDD)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Palo Alto Networks (PANW)
Amazon (AMZN)
Royal Caribbean Cruises Put Option (RCL)

View all positions for Parallax Volatility Advisers

Top funds holding Beam Therapeutics

ARK Investment Management
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Redmile Group
Yiheng Capital
Baillie Gifford & Co
Bellevue Group
Charles Schwab Investment Management
Dimensional Fund Advisors
Casdin Capital
Jpmorgan Chase & Co
Goldman Sachs Group
Tang Capital Management
Jane Street

View all funds holding Beam Therapeutics